CN102302564A - Pain stasis and paralysis eliminating powder for treating soft tissue injury - Google Patents
Pain stasis and paralysis eliminating powder for treating soft tissue injury Download PDFInfo
- Publication number
- CN102302564A CN102302564A CN201110273415A CN201110273415A CN102302564A CN 102302564 A CN102302564 A CN 102302564A CN 201110273415 A CN201110273415 A CN 201110273415A CN 201110273415 A CN201110273415 A CN 201110273415A CN 102302564 A CN102302564 A CN 102302564A
- Authority
- CN
- China
- Prior art keywords
- parts
- grieved
- blood stasis
- arthralgia due
- pain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Abstract
The invention relates to pain stasis and paralysis eliminating powder for treating soft tissue injury. The pain stasis and paralysis eliminating powder is mainly prepared from the following raw material drugs in parts by weight: 400 to 600 parts of rhubarb, 400 to 600 parts of frankincense, 400 to 600 parts of pseudo-ginseng, 725 to 925 parts of kadsura rootbark, and 650 to 850 parts of angelica. The invention also provides application of the pain stasis and paralysis eliminating powder for treating soft tissue injury. The pain stasis and paralysis eliminating powder has the advantages that: the pain stasis and paralysis eliminating power is compatible with a principle of Chinese medicament 'monarch, minister, assistant and guide'; and pharmacodynamic tests prove that the pain stasis and paralysis eliminating powder has the remarkable effects of activating blood and eliminating stasis, and reducing swelling and relieving pain. The powder is used for treating pains and swelling caused by acute and chronic soft tissue injuries, lumbar sprain, stiff neck and gonarthromeningitis, has small toxic or side effect, remarkable curative effect, low cost and is safe to administer convenient to manufacture, suitable for long-term use and easy for wide popularization, and thus the pain stasis and paralysis eliminating powder is a safe and effective external medicament for treating acute and chronic soft tissue injuries.
Description
Technical field
The present invention relates to a kind of Chinese medicine composition, specifically, is that a kind of grieved arthralgia due to blood stasis of treating soft tissue injury looses and application.
Background technology
Acute soft tissue injury is common clinical, frequently-occurring disease; The soft tissues such as skin, subcutaneous tissue, muscle, tendon, fascia, ligament, joint capsule, synovial membrane capsule, intervertebral disc, peripheral nerve and blood vessel that are meant human body receive the violence bump; Brute force is reversed; Caused damages such as tractive compressing, but do not have fracture or dislocation.Soft tissue receives the effect of external different causative factors of injury, surpasses soft tissue and can bear load when stress reaches certain intensity, causes the temporary transient disorder of the acute destruction of tissue morphology and tissue physiology's function and brings out damage, the generation symptom.Clinical manifestation is local pain, tenderness, swelling, livid purple ecchymosis, limb activity dysfunction etc.
The main pathological change of acute soft tissue injury is a principal character with local acute injury property inflammation and tissue repair.Acute soft tissue injury local organization pathological change mainly shows as aseptic inflammation, positive, the complicated stress that to be body take place harmful factor, its change basically be ooze out, necrosis and hypertrophy.Because the hemorrhage formation hematoma of the damage local capillary rupture in back, capillary permeability raises, and tissue fluid is outer in a large number to be seeped into interstice, and swelling, blood stasis appear in local organization.Swelling causes that local organization protectiveness spasm and wounded tissue damage pain in various degree then makes body generation dysfunction.This process causes histiocyte downright bad; Local little angiorrhexis; The stimulation blood vessel generation spasm of hemorrhage, blood stasis and causative factors of injury is destroyed local blood circulation, causes variation such as RBF, VPV, whole blood viscosity, blood plasma viscosity simultaneously and makes abnormal hemodynamics.In the process of inflammation, also there is multiple inflammatory mediator, they can act on local vascular alone or synergistically, and to strengthen vascular permeability, in these media, what play an important role has 5-hydroxy tryptamine (5-HT), a prostaglandin (P part E2) etc.
Acute soft tissue injury belongs to the category of " muscle and tendon injury " in orthopedics and traumatology of Chinese medicine is dialectical, " Yizong Jinjian bonesetting heart method main idea " record: " traumatic injury, blood stasis stagnates, swollen hard myospasm ".The main clinical manifestation that soft tissue injury is described is pain, swelling, dysfunction." element is asked, the big opinion of YIN YANG classification of natural phenomena " pointed out " impairment of QI resulting in pain, injury of configuration resulting in swelling ".Point out to damage local pain, swelling is the main disease performance of acute soft tissue injury, has reflected the pathological characters that local QI and blood meridian is impaired again." Prescriptions for Universal Relief is rolled over the wound door " speech " if roll over due to wound, interior moving grain, the road that blood is capable is improper to be led to, and the pain knot does not loose, and then is to swell to pain, controls and also removes the evil small house, makes qi and blood circulation, then can be also former." mean local channels damage blood oozing from the body openings or subcuta neous tissue arteries and veins and form hematoma or local stagnation of QI and blood outward, functional activity of QI being not smooth, qi and blood circulation is obstructed, dysfunction of the spleen in transportation and transformation, water-damp retention is local and cause swelling in limbs.When with the ruling by law of promoting the circulation of blood reducing swelling and alleviating pain it." Yizong Jinjian bonesetting heart method main idea " pointed out: " disease of traumatic injury is specially discussed from blood.The not broken and interior damage of skin the wounded has blood stasis more." disease of limb injury injures QI and blood more, the then stagnation of QI of feeling frustrated, blood trouble and blood stasis, the stagnation of QI can make blood stasis, and blood stasis is can choke capable, so that pathological changes is blood stasis, stagnates and swells and ache in the flesh table is then livid purple.Think that its essence is blood stasis, venation is damaged after the damage, and blood is from through forming the stasis of blood, the stasis of blood and heat-transformation.So the treatment general provisions are main with blood circulation promoting and blood stasis dispelling, promoting the circulation of QI to relieve pain, clearing away heat and cooling blood.
The main Therapeutic Method of doctor trained in Western medicine has: the symptomatology that braking, partial closure, physical therapy, anti-inflammation analgesis medicament etc., these methods also are not enough to control acute soft tissue injury effectively and are produced.And anti-inflammation analgesia medicine drug side effect commonly used is bigger, takes the function that can influence many organs and system for a long time in a large number.And traditional Chinese medical science treatment in this respect has long history, and outer treating method is many, though the Chinese patent medicine of some treatment soft tissue injurys is arranged; These medicines all have certain curative effect, but also have some problems, and are slow like some drug effect; Flavour of a drug are more, are not easy to preparation and use, and effect is not fairly obvious; Time of Administration is long, and curative effect is unstable or the like.
Summary of the invention
The objective of the invention is to deficiency of the prior art, provide a kind of grieved arthralgia due to blood stasis of treating soft tissue injury to loose.
One purpose more of the present invention is the application that provides a kind of grieved arthralgia due to blood stasis of treating soft tissue injury to loose.
For realizing above-mentioned purpose; The technical scheme that the present invention takes is: a kind of grieved arthralgia due to blood stasis of treating soft tissue injury looses, and it mainly is to be processed by following bulk drugs that described grieved arthralgia due to blood stasis looses: Radix Et Rhizoma Rhei 400-600 part, Olibanum 400-600 part, Radix Notoginseng 400-600 part, Cortex cercis chinensis 725-925 part, Radix Angelicae Sinensis 650-850 part.
It mainly is to be processed by following bulk drugs that described grieved arthralgia due to blood stasis looses: Radix Et Rhizoma Rhei 450-550 part, Olibanum 450-550 part, Radix Notoginseng 450-550 part, Cortex cercis chinensis 775-875 part, Radix Angelicae Sinensis 700-800 part.
It mainly is to be processed by following bulk drugs that described grieved arthralgia due to blood stasis looses: 500 parts of Radix Et Rhizoma Rhei, 500 parts of Olibanums, 500 parts of Radix Notoginseng, 825 parts of Cortex cercis chinensiss, 750 parts of Radix Angelicae Sinensis.
Described grieved arthralgia due to blood stasis looses and also comprises: Herba Taraxaci 1150-1350 part, Myrrha 400-600 part.
Described grieved arthralgia due to blood stasis looses and also comprises: Herba Taraxaci 1200-1300 part, Myrrha 450-550 part.
Described grieved arthralgia due to blood stasis looses and also comprises: 1250 parts of Herba Taraxacis, 500 parts of Myrrhas.
For realizing above-mentioned second purpose, the technical scheme that the present invention takes is: described grieved arthralgia due to blood stasis is dispersed in the pain due to preparation treatment acute or chronic soft tissue injury, lumbar sprain, stiff neck, the gonarthromeningitis, the application in the swelling disease medicament.
The invention has the advantages that:
The diffusing compatibility of grieved arthralgia due to blood stasis of the present invention meets Chinese medicine " monarch " principle, through the pharmacodynamic experiment checking, has the effect of significant blood circulation promoting and blood stasis dispelling, reducing swelling and alleviating pain.Be applicable to pain, swelling due to acute or chronic soft tissue injury, lumbar sprain, stiff neck, the gonarthromeningitis.Toxic and side effects is little, and is evident in efficacy, safe in utilization, with low cost, easy to make, is suitable for life-time service, is easy to extensive popularization, is a kind of medicine for external use of treatment acute or chronic soft tissue injury safely and effectively.
The specific embodiment
Below in conjunction with embodiment the specific embodiment provided by the invention is elaborated.
Embodiment 1 grieved arthralgia due to blood stasis loose (one)
400 parts of Radix Et Rhizoma Rhei, 600 parts of Olibanums, 400 parts of Radix Notoginseng, 925 parts of Cortex cercis chinensiss, 650 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
Embodiment 2 grieved arthralgia due to blood stasis loose (two)
600 parts of Radix Et Rhizoma Rhei, 400 parts of Olibanums, 600 parts of Radix Notoginseng, 725 parts of Cortex cercis chinensiss, 850 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
Embodiment 3 grieved arthralgia due to blood stasis loose (three)
450 parts of Radix Et Rhizoma Rhei, 550 parts of Olibanums, 450 parts of Radix Notoginseng, 875 parts of Cortex cercis chinensiss, 700 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
Embodiment 4 grieved arthralgia due to blood stasis loose (four)
550 parts of Radix Et Rhizoma Rhei, 450 parts of Olibanums, 550 parts of Radix Notoginseng, 775 parts of Cortex cercis chinensiss, 800 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
Embodiment 5 grieved arthralgia due to blood stasis loose (five)
500 parts of Radix Et Rhizoma Rhei, 500 parts of Olibanums, 500 parts of Radix Notoginseng, 825 parts of Cortex cercis chinensiss, 750 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
Embodiment 6 grieved arthralgia due to blood stasis loose (six)
500 parts of Radix Et Rhizoma Rhei, 1250 parts of Herba Taraxacis, 500 parts of Olibanums, 500 parts of Myrrhas, 500 parts of Radix Notoginseng, 825 parts of Cortex cercis chinensiss, 750 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
Embodiment 7 grieved arthralgia due to blood stasis loose (seven)
400 parts of Radix Et Rhizoma Rhei, 1350 parts of Herba Taraxacis, 400 parts of Olibanums, 600 parts of Myrrhas, 400 parts of Radix Notoginseng, 925 parts of Cortex cercis chinensiss, 650 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
Embodiment 8 grieved arthralgia due to blood stasis loose (eight)
600 parts of Radix Et Rhizoma Rhei, 1150 parts of Herba Taraxacis, 600 parts of Olibanums, 400 parts of Myrrhas, 600 parts of Radix Notoginseng, 725 parts of Cortex cercis chinensiss, 850 parts of Radix Angelicae Sinensis.Employing traditional method preparation according to prescription flavour of a drug fine ground end altogether, transfers with water, maltose that to mix pasty state subsequent use, during use prepared plaster is divided on kraft paper, and it is surperficial to cover plaster with tissue sheet, sticks at painful area during use.
The clinical trial that embodiment 9 grieved arthralgia due to blood stasis loose
One, materials and methods
(1) case is selected and is divided into groups
Include standard in: meet acute soft tissue injury diagnostic criteria and Chinese medical discrimination; The course of disease is no more than 3 days persons; Age 18-55 year; Sex is regardless of; The signature Informed Consent Form; Estimate effect of the present invention for better, make this checking that comparability, objectivity more arranged, with sprained ankle for going into the group standard.
Exclusion standard: do not meet the standard of including in; Gestation or women breast-feeding their children, allergic constitution or to this medicine allergy sufferers; Soft tissues such as fracture or muscle, tendon, ligament have fracture person fully; Be associated with serious primary disease such as cardiovascular, cerebrovascular, liver, kidney and hemopoietic system, serious systemic infection person, psychotic; The person that has the rheumatoid arthritis on inspection; , can't not judge curative effect, or data is not congruent affects the treatment or safety judgement person by the regulation medication.
Case is divided into groups: (GCP) stipulate according to State Food and Drug Administration's " GCP ", by the requirement of new Chinese medicine I clinical trial phase, need to observe 100 examples altogether.To be selected in the patient and be divided into the grieved arthralgia due to blood stasis plaster group of loosing at random, the grieved arthralgia due to blood stasis two plaster groups of loosing, Vitalin Emulgel group, ointment for orthopedics group.
(2) Therapeutic Method
Grieved arthralgia due to blood stasis looses one group: adopt embodiment 5 described method preparations, stick at the swelling pain position, be advisable to cover whole diseased region.Whenever changed dressings once at a distance from 24 hours, 1 week was 1 course of treatment, observed 2 courses of treatment.
Grieved arthralgia due to blood stasis looses two groups: adopt embodiment 6 described method preparations, stick at the swelling pain position, be advisable to cover whole diseased region.Whenever changed dressings once at a distance from 24 hours, 1 week was 1 course of treatment, observed 2 courses of treatment.
The Vitalin Emulgel group: use Vitalin Emulgel, provided by Novartis Co.,Ltd, specification 20g/ props up, the approval number of the drug: the accurate word H19990291 of traditional Chinese medicines, evenly to smear at the swelling pain position, and every day 2-4 time, 1 week was 1 course of treatment, observed 2 courses of treatment.
Ointment for orthopedics group: according to the preparation of the described method of Chinese patent publication number CN100544752C: 20 parts of 50 parts of Rhizoma Drynariae, 50 parts of Boraxs, 50 parts of Sanguis Draxonis, 50 parts of Olibanums, 50 parts of Myrrhas, 60 parts of Radix Angelicae Sinensis, 55 parts of Radix Dipsaci, 55 parts of Pyritums, 50 parts of ground beetle, 50 parts of Radix Et Rhizoma Rhei, 35 parts of Radix Notoginseng, 35 parts of Herba Lycopodiis, 30 parts of Radix Clematidis and Herba speranskiae tuberculataes; Decoct with Oleum sesami; Filter and remove residue; The concentrated pellet (Plumbum preparatium) that adds gets plaster after releasing fire-toxin is handled.Whenever changed dressings once at a distance from 24 hours, 1 week was 1 course of treatment, observed 2 courses of treatment.
(3) observation item
General data: sex, age, height, body weight, body temperature, resting heart rate, breathing, blood pressure etc.;
Lab index: anti-O, erythrocyte sedimentation rate, blood, urine routine test, liver, renal function etc.;
Health giving quality index: consider that major function of the present invention is pain relieving, detumescence,, adopt scoring mechanism method record so be main parameters for observation on effect with signs such as pain, swelling, mobilities.
A, pain intensity: 0 minute: painless; 1 minute: light pain, can recognize, do not have a rest but do not influence routine work, can not wake up because of pain; 2 minutes: in the pain, but can stand, the slight effect routine work was had a rest; 3 minutes: pain was heavy, is out of patience, and had a strong impact on routine work and had a rest, because of pain can not be fallen asleep.
B, swelling degree (comparing): 0 minute: no swelling with strong side; 1 minute: swelling was light, week footpath increase＜5%; 2 minutes: in the swelling, week footpath increase＞5%,＜10%; 3 minutes: swelling was heavy, week footpath increase＞10%.
C, mobility (comparing with strong side): 0 minute: activity freely; 1 minute: limitation of activity was light, and＜20%; 2 minutes: in the limitation of activity,＞20%,＜50%; 3 minutes: active receiving freight weight limit,＞50%.
D, ecchymosis degree: 1 minute: no ecchymosis; 2 minutes: the part was slightly livid purple, and area is less than 1 * 1cm; 3 minutes: local livid purple obvious, area was less than 4 * 4cm; 4 minutes: local livid purple obvious, area was greater than 4 * 4cm.
(4) observing time
A, each cardinal symptom, sign write down once respectively at first day on-test, the 3rd day, first weekend, the tenth day, second weekend.
Each is checked once and record before on-test and after finishing for b, safety indexes.
(5) therapeutic evaluation
Evaluation of clinical curative effect: according in the test to the scoring of pain, swelling, mobility, ecchymosis size, respectively with the overall improvement rate of calculating.Integration * 100% calculates the improvement rate before (integration before the treatment-treatment back integration)/treatment.Treatment back improvement rate>=90% is for curing; 70%～90% is produce effects; 30%～70% is produce effects;<30% is invalid
Safety evaluatio: patient main suit's untoward reaction, lab index reach unusually dermoreaction by certainly relevant, probably relevant, maybe be relevant, possibly have nothing to do and irrelevant certainly 5 grades of evaluation criterias evaluation.With certainly relevant, probably relevant, maybe relevant three's joint account untoward reaction rate, the untoward reaction degree must specifically describe record (the researcher signature is also dated).When untoward reaction takes place, observe the doctor and can whether end test according to state of an illness decision, the case of drug withdrawal should be carried out follow up survey to untoward reaction is arranged, recording processing process and result.
(6) statistical method
Carry out statistical procedures with the SPSS13.0 statistical package; Relatively use paired t-test before and after the group internal therapy; Measuring index between different groups adopts the t check or the variance analysis of design in groups, and the counting index adopts chi-square criterion, and relation adopts correlational analysis method between the different test items.
Two, experimental result
1. four groups of baselines relatively
Pain degree, swelling degree, mobility, ecchymosis situation, age before each group patient treatment are compared, and four groups are not all had significant difference (P＞0.05), see table 1.
Four groups of baselines of table 1 relatively
2. four groups of pain degrees relatively
Four groups relatively show, the diclofenac treatment got final product obvious alleviating pain in 3 days, and the diffusing two groups of treatments of grieved arthralgia due to blood stasis just can obviously reduce pain degree later in 7 days.Grieved arthralgia due to blood stasis looses and two looses one group at treatment 14 days and diclofenac group, ointment for orthopedics group and grieved arthralgia due to blood stasis and to compare the equal significance of difference (P < 0.05); Diffusing two curative effects of grieved arthralgia due to blood stasis were the most remarkable after two courses of treatment were treated in demonstration, and the diffusing one group of curative effect of ointment for orthopedics group and grieved arthralgia due to blood stasis is suitable basically.Being excellent in early stage with diclofenac for the intervention degree of pain degree promptly, secondly is that grieved arthralgia due to blood stasis looses two, grieved arthralgia due to blood stasis looses one, is ointment for orthopedics at last.The treatment later stage then is the diffusing two＞diclofenac of grieved arthralgia due to blood stasis＞diffusing one＞ointment for orthopedics of grieved arthralgia due to blood stasis successively.See table 2.
Four groups of pain degrees of table 2 relatively
| Group | Before the treatment | Treated 3 days | Treated 7 days | Treated 10 days | Treated 14 days |
| Diffusing one (n=20) of grieved arthralgia due to blood stasis | 2.60±0.45 | 2.38±0.43 | 2.05±0.48* | 1.68±0.52*# | 0.33±0.29*# |
| Diffusing two (n=27) of grieved arthralgia due to blood stasis | 2.52±0.45 | 2.24±0.52* | 1.94±0.59* | 1.39±0.56* | 0* |
| Diclofenac (n=21) | 2.41±0.48 | 1.64±0.47*# | 0.80±0.37*# | 0.50±0.31*# | 0.32±0.29*# |
| Ointment for orthopedics (n=21) | 2.45±0.45 | 2.39±0.45 | 2.06±0.52* | 1.65±0.41*# | 0.38±0.32*# |
* with before the treatment compare difference statistical significance (P < 0.05) is arranged;
# and grieved arthralgia due to blood stasis loose two groups and compare difference statistical significance (P < 0.05) is arranged.
3. four groups of swelling degree relatively
Four groups relatively show, grieved arthralgia due to blood stasis looses two, grieved arthralgia due to blood stasis looses, and a treatment can obviously be alleviated swelling in 3 days, reduced the swelling degree, and compare difference before the treatment statistical significance (P < 0.05) is all arranged, and the diclofenac group is at treatment obvious alleviating pain after 7 days; Relatively more visible between group; Diffusing two curative effects of grieved arthralgia due to blood stasis are the most remarkable aspect the swelling alleviation; Treating loose one group with diclofenac, ointment for orthopedics and grieved arthralgia due to blood stasis in 3,7,10 days compares difference statistical significance (P < 0.05) is all arranged; Treat and compared difference in 14 days with diclofenac and still have statistical significance (P < 0.05), promptly four groups of intervention degree for the swelling degree are grieved arthralgia due to blood stasis two＞grieved arthralgia due to blood stasis, the one＞ointment for orthopedics＞diclofenac that looses that looses successively.See table 3.
Four groups of swelling degree of table 3 relatively
| Group | Before the treatment | Treated 3 days | Treated 7 days | Treated 10 days | Treated 14 days |
| Diffusing one (n=20) of grieved arthralgia due to blood stasis | 2.55±0.43 | 2.10±0.48*# | 1.78±0.50*# | 1.38±0.56*# | 0.48±0.47* |
| Diffusing two (n=27) of grieved arthralgia due to blood stasis | 2.52±0.43 | 1.72±0.53* | 0.98±0.63* | 0.48±0.40* | 0.26±0.25* |
| Diclofenac (n=21) | 2.30±0.40 | 2.16±0.36# | 1.89±0.43*# | 1.50±0.49*# | 0.68±0.42*# |
| Ointment for orthopedics (n=21) | 2.40±0.41 | 2.18±0.43# | 1.90±0.36*# | 1.49±0.58*# | 0.50±0.73*# |
* with before the treatment compare difference statistical significance (P < 0.05) is arranged;
# and grieved arthralgia due to blood stasis loose two groups and compare difference statistical significance (P < 0.05) is arranged.
4. four groups of mobilities relatively
Four groups relatively show, grieved arthralgia due to blood stasis looses two, grieved arthralgia due to blood stasis looses one, the ointment for orthopedics treatment can obviously improve mobility in 3 days, and compare difference before the treatment statistical significance (P < 0.05) is all arranged, and the diclofenac group can obviously improve mobility in treatment after 7 days; Relatively more visible between group; Diffusing two curative effects of grieved arthralgia due to blood stasis are the most remarkable aspect the raising mobility; Treating loose one group with diclofenac, ointment for orthopedics and grieved arthralgia due to blood stasis in 3,7,10 days compares difference statistical significance (P < 0.05) is all arranged; Treat and compared difference in 14 days with diclofenac and still have statistical significance (P < 0.05), promptly four groups of intervention degree for mobility are the powder for dispersing blood stasis＞side of simplifying＞ointment for orthopedics＞diclofenac successively.See table 4.
Four groups of mobilities of table 4 relatively
| Group | Before the treatment | Treated 3 days | Treated 7 days | Treated 10 days | Treated 14 days |
| Diffusing one (n=20) of grieved arthralgia due to blood stasis | 2.58±0.47 | 2.18±0.47*# | 1.93±0.34*# | 1.50±0.49*# | 0.43±0.37* |
| Diffusing two (n=27) of grieved arthralgia due to blood stasis | 2.52±0.43 | 1.72±0.45* | 0.96±0.55* | 0.48±0.43* | 0.30±0.29* |
| Diclofenac (n=21) | 2.64±0.41 | 2.45±0.41# | 1.95±0.48*# | 1.55±0.53*# | 0.75±0.46*# |
| Ointment for orthopedics (n=21) | 2.60±0.49 | 2.20±0.50*# | 1.95±0.42*# | 1.49±0.46*# | 0.49±0.51* |
* with before the treatment compare difference statistical significance (P < 0.05) is arranged;
# compares difference statistical significance (P < 0.05) is arranged with the group of become silted up loosing of disappearing.
5. four groups of ecchymosis degree relatively
Four groups relatively show, grieved arthralgia due to blood stasis looses two, grieved arthralgia due to blood stasis looses one, the ointment for orthopedics treatment can obviously be eliminated ecchymosis in 3 days, and compare difference before the treatment statistical significance (P < 0.05) is all arranged, and the diclofenac group can obviously be eliminated ecchymosis in treatment after 7 days; Relatively more visible between group; Diffusing two curative effects of grieved arthralgia due to blood stasis are the most remarkable aspect the elimination ecchymosis; Treat and compared difference in 3,7,10 days with the diclofenac group statistical significance (P < 0.05) is all arranged, promptly four groups of intervention degree for the ecchymosis degree are the powder for dispersing blood stasis＞side of simplifying＞ointment for orthopedics＞diclofenac successively.See table 5.
Table 5 ecchymosis degree relatively
| Group | Before the treatment | Treated 3 days | Treated 7 days | Treated 10 days | Treated 14 days |
| Diffusing one (n=20) of grieved arthralgia due to blood stasis | 3.25±0.64 | 2.40±0.48* | 1.60±0.60* | 1.35±0.37* | 1.08±0.18* |
| Diffusing two (n=27) of grieved arthralgia due to blood stasis | 3.04±0.81 | 2.30±0.86* | 1.43±0.45* | 1.31±0.37* | 1.04±0.13* |
| Diclofenac (n=21) | 3.05±0.65 | 2.98±0.70# | 2.36±0.60*# | 1.80±0.48*# | 1.23±0.30* |
| Ointment for orthopedics (n=21) | 3.08±0.55 | 2.45±0.52* | 1.62±0.78* | 1.40±0.25* | 1.10±0.28* |
* with before the treatment compare difference statistical significance (P < 0.05) is arranged;
# compares difference statistical significance (P < 0.05) is arranged with the group of become silted up loosing of disappearing.
6. safety evaluatio
For guaranteeing drug safety; Blood before and after the patient treatment, routine urinalysis, hepatic and renal function, anti-" O ", erythrocyte sedimentation rate each item index are detected, and each item result is all in normal range, though only there is grieved arthralgia due to blood stasis one group of ESR difference before and after treatment of loosing that statistical significance (P < 0.05) is arranged before and after the treatment; But all in normal range; The patient does not have clinical malaise symptoms yet, so belong to normal difference, proves absolutely that four kinds of medicines all have higher clinical safety.See table 6, table 7.
Blood, routine urinalysis are relatively before and after four groups of treatments of table 6
Hepatic and renal function, anti-" O ", erythrocyte sedimentation rate are relatively before and after four groups of treatments of table 7
* each group and treatment back comparing difference have statistical significance (P < 0.05).
Three, conclusion
Result of study of the present invention shows, grieved arthralgia due to blood stasis looses two groups and aspect four of pain degrees, swelling degree, mobility, ecchymosis degree, compares the prognosis optimum with loose one group, ointment for orthopedics group of grieved arthralgia due to blood stasis with the diclofenac group.Only diclofenac is very fast in treatment initial stage onset aspect pain degree; This possibly be because the Main Ingredients and Appearance of diclofenac is that non-steroidal anti-inflammatory analgesics thing diclofenac sodium is relevant; Though and two onsets of loosing of grieved arthralgia due to blood stasis are slightly slow but stable curative effect finally still is higher than diclofenac lastingly; Curative effect is not as good as diclofenac aspect pain relief for grieved arthralgia due to blood stasis diffusing, and other three aspects all are superior to the diclofenac group.
Compare with diclofenac, though grieved arthralgia due to blood stasis looses and one to loose with grieved arthralgia due to blood stasis and two to have the slightly slow stable curative effect of onset, toxic and side effects is little, compares with ointment for orthopedics, flavour of a drug number of the present invention still less, better efficacy, using clinically has better effect.
It is to process by monarch, minister, the combination principle helping, make that grieved arthralgia due to blood stasis of the present invention looses.Radix Et Rhizoma Rhei heat-clearing and toxic substances removing in the side, blood circulation promoting and blood stasis dispelling; Olibanum, Radix Notoginseng removing stasis to stop bleeding, the analgesic therapy detumescence; Cortex cercis chinensis promoting blood circulation and detoxication, removing heat from blood detumescence; The Radix Angelicae Sinensis regulating blood flow to alleviate pains.Analyzing Radix Et Rhizoma Rhei according to modern pharmacology has significant antiinflammatory and function of promoting blood circulation to disperse blood clots, and the boswellic acid compounds in the Olibanum is to have unique anti-inflammatory mechanisms, the non-steroidal plant antiinflammatory that untoward reaction is little; Radix Notoginseng then has good promoting blood circulation and hemostasis effect; Cortex cercis chinensis has anti-inflammatory and antalgic and reaches the spasmolysis to muscle, and Radix Angelicae Sinensis has antithrombotic and changes hemorheological effect.Result of study of the present invention shows that the diffusing plaster treatment of grieved arthralgia due to blood stasis acute soft tissue injury is evident in efficacy, safe in utilization, with low cost, easy to make, is easy to extensive popularization, is a kind of medicine for external use of treating acute soft tissue injury preferably.
The above only is a preferred implementation of the present invention; Should be pointed out that for those skilled in the art, under the prerequisite that does not break away from the inventive method; Can also make some improvement and replenish, these improvement and replenish and also should be regarded as protection scope of the present invention.
Claims (7)
1. a grieved arthralgia due to blood stasis of treating soft tissue injury looses; It is characterized in that it mainly is to be processed by following bulk drugs that described grieved arthralgia due to blood stasis looses: Radix Et Rhizoma Rhei 400-600 part, Olibanum 400-600 part, Radix Notoginseng 400-600 part, Cortex cercis chinensis 725-925 part, Radix Angelicae Sinensis 650-850 part.
2. grieved arthralgia due to blood stasis according to claim 1 looses; It is characterized in that it mainly is to be processed by following bulk drugs that described grieved arthralgia due to blood stasis looses: Radix Et Rhizoma Rhei 450-550 part, Olibanum 450-550 part, Radix Notoginseng 450-550 part, Cortex cercis chinensis 775-875 part, Radix Angelicae Sinensis 700-800 part.
3. grieved arthralgia due to blood stasis according to claim 2 looses, and it is characterized in that, it mainly is to be processed by following bulk drugs that described grieved arthralgia due to blood stasis looses: 500 parts of Radix Et Rhizoma Rhei, 500 parts of Olibanums, 500 parts of Radix Notoginseng, 825 parts of Cortex cercis chinensiss, 750 parts of Radix Angelicae Sinensis.
4. loose according to the arbitrary described grieved arthralgia due to blood stasis of claim 1-3, it is characterized in that, described grieved arthralgia due to blood stasis looses and also comprises: Herba Taraxaci 1150-1350 part, Myrrha 400-600 part.
5. loose according to the arbitrary described grieved arthralgia due to blood stasis of claim 1-3, it is characterized in that, described grieved arthralgia due to blood stasis looses and also comprises: Herba Taraxaci 1200-1300 part, Myrrha 450-550 part.
6. loose according to the arbitrary described grieved arthralgia due to blood stasis of claim 1-3, it is characterized in that, described grieved arthralgia due to blood stasis looses and also comprises: 1250 parts of Herba Taraxacis, 500 parts of Myrrhas.
7. be dispersed in the pain due to preparation treatment acute or chronic soft tissue injury, lumbar sprain, stiff neck, the gonarthromeningitis, the application in the swelling disease medicament according to the arbitrary described grieved arthralgia due to blood stasis of claim 1-6.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110273415 CN102302564B (en) | 2011-09-15 | 2011-09-15 | Pain stasis and paralysis eliminating powder for treating soft tissue injury |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201110273415 CN102302564B (en) | 2011-09-15 | 2011-09-15 | Pain stasis and paralysis eliminating powder for treating soft tissue injury |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102302564A true CN102302564A (en) | 2012-01-04 |
| CN102302564B CN102302564B (en) | 2013-09-18 |
Family
ID=45376547
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201110273415 Active CN102302564B (en) | 2011-09-15 | 2011-09-15 | Pain stasis and paralysis eliminating powder for treating soft tissue injury |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102302564B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107773716A (en) * | 2016-08-20 | 2018-03-09 | 张向阳中医诊所 | A kind of plaster for treating acute soft tissue injury |
| CN110538272A (en) * | 2019-09-11 | 2019-12-06 | 李松岭 | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1291496A (en) * | 2000-09-02 | 2001-04-18 | 杨献志 | Plaster 'Gucixiao' and its preparing process |
| CN101062377A (en) * | 2007-06-01 | 2007-10-31 | 张瑞 | Adhesive plaster for diminishing inflammation, expelling wind and cold and so on and its preparation method |
| CN101279080A (en) * | 2008-06-04 | 2008-10-08 | 金秀英 | Medicament composition for curing cervical vertebra disease, lumbar disease and traumatic injury and preparation |
-
2011
- 2011-09-15 CN CN 201110273415 patent/CN102302564B/en active Active
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1291496A (en) * | 2000-09-02 | 2001-04-18 | 杨献志 | Plaster 'Gucixiao' and its preparing process |
| CN101062377A (en) * | 2007-06-01 | 2007-10-31 | 张瑞 | Adhesive plaster for diminishing inflammation, expelling wind and cold and so on and its preparation method |
| CN101279080A (en) * | 2008-06-04 | 2008-10-08 | 金秀英 | Medicament composition for curing cervical vertebra disease, lumbar disease and traumatic injury and preparation |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN107773716A (en) * | 2016-08-20 | 2018-03-09 | 张向阳中医诊所 | A kind of plaster for treating acute soft tissue injury |
| CN110538272A (en) * | 2019-09-11 | 2019-12-06 | 李松岭 | swelling-reducing and collateral-dredging powder for treating soft tissue injury and joint swelling and pain and preparation method thereof |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102302564B (en) | 2013-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102302565B (en) | Stasis eliminating powder for treating soft tissue injury and cervical spondylosis | |
| CN103690623B (en) | Medicated wine for treating traumatic injury | |
| CN102302564B (en) | Pain stasis and paralysis eliminating powder for treating soft tissue injury | |
| WO2012100754A1 (en) | Chinese medicine composition for treating stab wounds, burns, and various traumas | |
| CN100404052C (en) | External use Chinese herbal medicine ointment for treating mammary cancer and lymph cancer | |
| CN102389561B (en) | Externally applied hot washing traditional Chinese medicinal composition for blood circulation invigorating and pain relieving and application thereof | |
| CN102793878A (en) | Gout fast analgesic paste | |
| CN103142707A (en) | Traditional Chinese medicine paste or treating chronic soft tissue injury and preparation method thereof | |
| CN103705658B (en) | A kind of external traditional Chinese medicinal application for the treatment of rheumatoid arthritis | |
| CN103585294B (en) | A kind of for plaster treating hyperosteogeny and preparation method thereof | |
| CN101940652B (en) | Chinese medicinal liniment for treating psoriasis, multiple kinds of stubborn dermatitis and pruritus | |
| CN105168629A (en) | Traditional Chinese medicine gel for treating qi-stagnation and blood stasis type decubitus | |
| CN104147174A (en) | Medicament for treating stroke | |
| CN104815090B (en) | A kind of external preparation and preparation method thereof for treating closed injury | |
| CN104606455B (en) | A kind of medicament for the treatment of lumbar muscle strain | |
| CN110302271B (en) | Cape jasmine capable of dispelling cold and preparation method thereof | |
| CN115154504B (en) | Traditional Chinese medicine composition for treating yang deficiency and blood stasis type gonarthritis as well as preparation method and application thereof | |
| CN104257967B (en) | A kind of Chinese medicine for treating injury gained in sports | |
| CN102225125B (en) | Externally applied traditional Chinese medicine composite for treating joint pain caused by rheumatoid arthritis and preparation method thereof | |
| CN110420305B (en) | Traditional Chinese medicine composition for treating chronic muscle injuries and preparation method thereof | |
| CN102205018B (en) | Traditional Chinese medicinal lotion for treating abdominal wall fascitis | |
| CN104474517A (en) | Chinese patent medicine for treating cervical syndrome and preparation method | |
| CN104491799B (en) | A kind of traditional Chinese powder medicine for application treatment rheumatoid arthritis | |
| CN106539910B (en) | Traditional Chinese medicine composition containing radix aconiti and application thereof | |
| CN105381089A (en) | Traditional Chinese medicine lotion for treating skin itch of uremia patient and nursing method |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant |